Skip to search formSkip to main contentSkip to account menu
  • Publications
  • Influence
The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory.
TLDR
The historical evolution, development, rationale and validation of the Hopkins Symptom Checklist is described, a self-report symptom inventory comprised of 58 items which are representative of the symptom configurations commonly observed among outpatients.
View on PubMed
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
TLDR
Comparisons of the nine primary symptom dimensions of the SCL-90 with the set of MMPI scales reflected very high convergent validity for the Scl-90, with secondary patterns of correlations showing high interpretative consistency.
View on Cambridge Press
The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions.
View on PubMed
Short form of depression inventory: cross-validation.
View on PubMed
Psychiatric illness in family practice.
TLDR
For the majority of "high distress" patients, pharmacotherapy was considered the treatment of choice by physicians, and high concordance existed between the "case" assessment by the physician and the patient's own rating of distress.
View on PubMed
Symptoms of Emotional Distress in a Family Planning Service: Stability over a Four-Week Period
Summary The 25-item Hopkins Symptom Checklist (HSCL–25) was used on two occasions four weeks apart to identify self-reported symptoms of anxiety and depression in patients attending a family planning…
View on Cambridge Press
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.
TLDR
GAD is the most common anxiety disorder in primary care and is highly debilitating, and it is frequently comorbid with depression and other anxiety disorders, which exacerbates functional impairment.
View on PubMed
Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
TLDR
The results of the study need replication, but suggest a potentially important role for antidepressants, particularly imipramine, in patients suffering from GAD.
View on PubMed
Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
TLDR
Vilazodone is effective for the treatment of MDD in adults, with symptom relief starting at 1 week, and is well tolerated at a dose of 40 mg/day, according to the intention-to-treat sample.
View on PubMed
A Comparison of Two Psychiatric Screening Tests
TLDR
A comparison is made between the General Health Questionnaire (GHQ) and the Symptom Checklist (SCL) as psychiatric screening tests in community-based research projects, which revealed high correlations between the symptoms of anxiety and depression.
View on Cambridge Press
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License